SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Mortensen Leif Spange)
 

Sökning: WFRF:(Mortensen Leif Spange) > (2017) > Long-term efficacy ...

  • Nielsen, Jens CosedisAarhus Univ Hosp, Aarhus, Denmark,Aarhus University Hospital, Denmark (författare)

Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation : 5-year outcome in a randomised clinical trial.

  • Artikel/kapitelEngelska2017

Förlag, utgivningsår, omfång ...

  • 2016-08-26
  • BMJ Publishing Group Ltd,2017
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-57434
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-57434URI
  • https://doi.org/10.1136/heartjnl-2016-309781DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-133317URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding agenciesDanish Heart Foundation, grant no:  05-4-B284-A466-22237 Biosense Webster
  • Funding agencies: Danish Heart Foundation [05-4-B284-A466-22237]; Biosense Webster
  • OBJECTIVE: The Medical ANtiarrhythmic Treatment or Radiofrequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial compared radiofrequency catheter ablation (RFA) with antiarrhythmic drug therapy (AAD) as first-line treatment for paroxysmal atrial fibrillation (AF). Endpoint of ablation was elimination of electrical activity inside pulmonary veins. We present the results of the 5-year follow-up.METHODS: This pre-specified 5-year follow-up included assessment of any AF and symptomatic AF burden by one 7-day Holter recording and quality of life (QoL) assessment, using SF-36 questionnaire physical and mental component scores. Analysis was intention-to-treat. Imputation was used to compensate for missing Holter data.RESULTS: 245 of 294 patients (83%) randomised to RFA (n=125) or AAD (n=120) attended the 5-year follow-up, 227 with Holter recording. Use of class I or III AAD was more frequent in AAD group (N=61 vs 13, p<0.001). More patients in the RFA group were free from AF (126/146 (86%) vs 105/148 (71%), p=0.001, relative risk (RR) 0.82; 95% CI 0.73 to 0.93) and symptomatic AF (137/146 (94%) vs 126/148 (85%), p=0.015, χ(2) test, RR 0.91; 95% CI 0.84 to 0.98) in 7-day Holter recording. AF burden was significantly lower in the RFA group (any AF: p=0.003; symptomatic AF: p=0.02). QoL scores did not differ between randomisation groups. QoL scores remained improved from baseline (both components p<0.001), and did not differ from 2-year scores.CONCLUSIONS: At 5 years, the occurrence and burden of any AF and symptomatic AF were significantly lower in the RFA group than in the AAD group. Improved QoL scores observed after 2 years persisted after 5 years without between-group differences.TRIAL REGISTRATION NUMBER: NCT00133211; Results.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Johannessen, ArneGentofte University Hospital, Copenhagen, Denmark (författare)
  • Raatikainen, PekkaHeart Center Co. Tampere University Hospital, Tampere, Finland (författare)
  • Hindricks, GerhardLeipzig University Hospital, Leipzig, Germany (författare)
  • Walfridsson, HåkanLinköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US(Swepub:liu)hakwa83 (författare)
  • Pehrson, Steen MichaelDepartment of Cardiology, The Heart Center, Rigshospitalet, Copenhagen, Denmark (författare)
  • Englund, AndersRegion Örebro län,Department of Medicine, Örebro University Hospital, Örebro, Sweden (författare)
  • Hartikainen, JuhaKuopio University Hospital, Kuopio, Finland (författare)
  • Mortensen, Leif SpangeUNI-C, Danish Information Technology Centre for Education and Research, Aarhus, Denmark (författare)
  • Mantra-Paf Investigators, Group Author (författare)
  • Steen Hansen, PeterMANTRA-PAF Investigators. UNI-C, Danish Information Technology Centre for Education and Research, Aarhus, Denmark (författare)
  • Aarhus Univ Hosp, Aarhus, DenmarkAarhus University Hospital, Denmark (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Heart: BMJ Publishing Group Ltd103:5, s. 368-3761355-60371468-201X

Internetlänk

Hitta via bibliotek

  • Heart (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy